Documents

Discussions Technicals Forecast Seasonals Options

Athira Pharma, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Athira Pharma, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 07, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 09, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Feb 27, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 07, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 01, 2024

Quarterly report10-Q

Earnings release8-K

Status Update

Jun 18, 2024

Slides

Q1 2024

May 15, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Feb 22, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 09, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 10, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 23, 2023

Annual report10-K

Earnings release8-K

Virtual R&D Event 2022

Dec 07, 2022

Slides

Q3 2022

Nov 10, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 15, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 12, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 24, 2022

Annual report10-K

Earnings release8-K

Q3 2021

Nov 10, 2021

Quarterly report10-Q

Q2 2021

Aug 16, 2021

Quarterly report10-Q

Earnings release8-K

Q1 2021

May 13, 2021

Quarterly report10-Q

Earnings release8-K

2020

Q4 2020

Mar 25, 2021

Annual report10-K

Earnings release8-K